Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The 2025 World Health Organization guideline now recommends GLP-1 therapies (liraglutide, semaglutide, and tirzepatide) as part of long-term obesity treatment in adults, paired with lifestyle interventions (WHO)
Key Takeaways GLP-1 medications like semaglutide and tirzepatide start at low doses and increase gradually to help the body adjust and reduce side effects
Result: tirzepatide 20.2% mean weight loss vs
Bottom line: For patients with severe obesity (BMI 35), bariatric surgery still provides superior long-term outcomesand it does so reliably, without being derailed by market forces
We have these different tools that work for different patients. Fitt thinks an integrated approach is key to bariatric surgery programs moving forward
& Sundler, F
US$ 25.52
US$ 21.48
US$ 21.06
US$ 20.15
US$ 21.44
US$ 25.71
US$ 23.26
US$ 26.40
US$ 21.97
